Jpmorgan Chase & CO Omega Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 503 shares of OMGA stock, worth $377. This represents 0.0% of its overall portfolio holdings.

Number of Shares
503
Previous 504 0.2%
Holding current value
$377
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
SELL
$1.22 - $2.25 $1 - $2
-1 Reduced 0.2%
503 $0
Q3 2024

Nov 08, 2024
SELL
$1.22 - $2.25 $1 - $2
-1 Reduced 0.2%
503 $0
Q2 2024

Dec 26, 2024
BUY
$1.86 - $3.2 $1 - $3
1 Added 0.2%
504 $1,000
Q2 2024

Aug 12, 2024
SELL
$1.86 - $3.2 $17,844 - $30,700
-9,594 Reduced 95.01%
504 $1,000
Q1 2024

Dec 26, 2024
BUY
$2.73 - $5.32 $26,194 - $51,045
9,595 Added 1907.55%
10,098 $36,000
Q1 2024

May 10, 2024
SELL
$2.73 - $5.32 $15,558 - $30,318
-5,699 Reduced 36.08%
10,098 $36,000
Q4 2023

Dec 26, 2024
BUY
$1.35 - $3.21 $20,646 - $49,093
15,294 Added 3040.56%
15,797 $47,000
Q4 2023

Feb 12, 2024
SELL
$1.35 - $3.21 $13,911 - $33,079
-10,305 Reduced 39.48%
15,797 $47,000
Q3 2023

Nov 14, 2023
BUY
$2.15 - $5.68 $10,274 - $27,144
4,779 Added 22.41%
26,102 $56,000
Q2 2023

Aug 11, 2023
BUY
$5.6 - $9.66 $109,978 - $189,712
19,639 Added 1166.21%
21,323 $119,000
Q1 2023

May 11, 2023
BUY
$4.81 - $10.95 $615 - $1,401
128 Added 8.23%
1,684 $10,000
Q4 2022

Feb 13, 2023
SELL
$4.22 - $7.05 $5,165 - $8,629
-1,224 Reduced 44.03%
1,556 $9,000
Q3 2022

Nov 14, 2022
BUY
$3.63 - $6.65 $3,183 - $5,832
877 Added 46.09%
2,780 $15,000
Q2 2022

Aug 11, 2022
SELL
$2.01 - $7.19 $32,817 - $117,391
-16,327 Reduced 89.56%
1,903 $7,000
Q1 2022

May 11, 2022
BUY
$6.24 - $14.04 $57,676 - $129,771
9,243 Added 102.85%
18,230 $113,000
Q4 2021

Feb 10, 2022
BUY
$11.33 - $29.38 $69,736 - $180,833
6,155 Added 217.34%
8,987 $102,000
Q3 2021

Nov 12, 2021
BUY
$16.0 - $22.51 $45,312 - $63,748
2,832 New
2,832 $53,000

Others Institutions Holding OMGA

# of Institutions
58
Shares Held
43.4M
Call Options Held
25.8K
Put Options Held
7K
View Full List

About Omega Therapeutics, Inc.

OMGA Quotes by TradingView
  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $35.9M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email